Immuron Ltd. | Key People and Executives
Richard J. Berman
Non-Executive Director
Ravi Savarirayan
Non-Executive Director
Peter Anastasiou
Executive Vice Chairman
Stephen Anastasiou
Non-Executive Director
Roger Aston
Non-Executive Chairman
Daniel Jude Pollock
Independent Non-Executive Director
Jerry Kanellos
CEO, Chief Operating & Scientific Officer
Phillip Allen Hains
Chief Financial Officer & Secretary
Dan Peres
Medical Director
Neta Tobis
Clinical Director
Reza Moussakhani
Director-Manufacturing Quality
Richard J. Berman
Non-Executive Director
Ravi Savarirayan
Non-Executive Director
Peter Anastasiou
Executive Vice Chairman
Stephen Anastasiou
Non-Executive Director
Travis Robins
Director-US Sales
Roger Aston
Non-Executive Chairman
Daniel Jude Pollock
Independent Non-Executive Director
Address |
62 Lygon Street Carlton Victoria (VIC) 3053 Australia
|
Employees
|
- |
Website |
http://www.immuron.com |
Updated |
07/08/2019 |
Immuron Ltd. engages in the research and development of oral immunotherapy treatments using dairy-derived antibody products for humans. It operates through the following segments: Research and Development; HyperImmune Products; and Corporate. The Research and Development segment involves the research and development projects performed in Australia and Israel. |